Tumor Regression Grade of Urothelial Bladder Cancer After Neoadjuvant Chemotherapy

The American Journal of Surgical Pathology ◽

10.1097/pas.0000000000000142 ◽

2014 ◽

Vol 38 (3) ◽

pp. 325-332 ◽

Author(s):

Achim Fleischmann ◽

George N. Thalmann ◽

Aurel Perren ◽

Roland Seiler

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Tumor Regression ◽

Tumor Regression Grade ◽

Urothelial Bladder Cancer ◽

Urothelial Bladder ◽

Regression Grade

Download Full-text

1907 NEOADJUVANT CHEMOTHERAPY FOR UROTHELIAL BLADDER CANCER: TUMOR REGRESSION IS AN INDEPENDENT PREDICTOR OF SURVIVAL

The Journal of Urology ◽

10.1016/j.juro.2012.02.2063 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

Roland Seiler ◽

Achim Fleischmann ◽

Aurel Perren ◽

George N. Thalmann

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Tumor Regression ◽

Independent Predictor ◽

Urothelial Bladder Cancer ◽

Cancer Tumor ◽

Urothelial Bladder

Download Full-text

Independent multicenter validation of the prognostic significance of histopathologic tumor regression grade after neoadjuvant chemotherapy in bladder cancer

European Urology Supplements ◽

10.1016/s1569-9056(19)30466-x ◽

2019 ◽

Vol 18 (1) ◽

pp. e632-e633

Author(s):

C.S. Voskuilen ◽

H.Z. Oo ◽

V. Genitsch ◽

L.A. Smit ◽

A. Vidal ◽

...

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Tumor Regression ◽

Prognostic Significance ◽

Tumor Regression Grade ◽

Regression Grade ◽

Multicenter Validation

Download Full-text

Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2018.09.008 ◽

2019 ◽

Vol 37 (1) ◽

pp. 1-11 ◽

Author(s):

Soroush T. Bazargani ◽

Thomas G. Clifford ◽

Hooman Djaladat ◽

Anne K. Schuckman ◽

Kevin Wayne ◽

...

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Tumor Marker ◽

Urothelial Bladder Cancer ◽

Epithelial Tumor ◽

Oncological Outcomes ◽

Urothelial Bladder ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

Neoadjuvant chemotherapy in urothelial bladder cancer: impact of regimen and variant histology

Future Oncology ◽

10.2217/fon-2016-0056 ◽

2016 ◽

Vol 12 (15) ◽

pp. 1795-1804 ◽

Author(s):

Hristos Z Kaimakliotis ◽

M Francesca Monn ◽

Jane S Cho ◽

Jose A Pedrosa ◽

Noah M Hahn ◽

...

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Urothelial Bladder Cancer ◽

Urothelial Bladder ◽

Variant Histology

Download Full-text

Pathologic down-staging following standard (SD) MVAC (methotrexate-vinblastine-doxorubicine-cisplatin) or dose-dense MVAC (DD) neoadjuvant chemotherapy (NC) for muscle-invasive urothelial bladder cancer (UC): A retrospective multicenter cohort of the French Genitourinary Tumor Group (GETUG/AFU).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.4550 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 4550-4550 ◽

Author(s):

Damien Pouessel ◽

Sylvie Chevret ◽

Emmanuelle Bompas ◽

Laurys Boudin ◽

Charlotte Joly ◽

...

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Urothelial Bladder Cancer ◽

Multicenter Cohort ◽

Tumor Group ◽

Urothelial Bladder ◽

Muscle Invasive ◽

Download Full-text

650 A multi-institutional analysis of pathological and survival outcomes in patients with clinically node positive urothelial bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy

European Urology Supplements ◽

10.1016/s1569-9056(15)60643-1 ◽

2015 ◽

Vol 14 (2) ◽

pp. e650-e650a

Author(s):

K. Zargar-Shoshtari ◽

H. Zargar ◽

A.S. Fairey ◽

L.S. Mertens ◽

C.P. Dinney ◽

...

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Radical Cystectomy ◽

Institutional Analysis ◽

Survival Outcomes ◽

Urothelial Bladder Cancer ◽

Node Positive ◽

Urothelial Bladder ◽

Clinically Node Positive

Download Full-text

Neoadjuvant chemotherapy in patients with urothelial bladder cancer

European Urology Open Science ◽

10.1016/s2666-1683(21)03227-4 ◽

2021 ◽

Vol 33 ◽

pp. S414

Author(s):

R. Catarino ◽

L. Alves ◽

J. Pereira ◽

D. Pereira ◽

G. Costa ◽

...

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Urothelial Bladder Cancer ◽

Urothelial Bladder

Download Full-text

Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Carcinoma

The American Journal of Surgical Pathology ◽

10.1097/pas.0000000000001371 ◽

2019 ◽

pp. 1

Author(s):

Charlotte S. Voskuilen ◽

Htoo Zarni Oo ◽

Vera Genitsch ◽

Laura A. Smit ◽

Alvaro Vidal ◽

...

Keyword(s):

Neoadjuvant Chemotherapy ◽

Bladder Carcinoma ◽

Tumor Regression ◽

Tumor Regression Grade ◽

Muscle Invasive ◽

Regression Grade ◽

Multicenter Validation

Download Full-text

Faculty Opinions recommendation of Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.716398050.791902844 ◽

2012 ◽

Author(s):

Levent Turkeri ◽

Ilker Tinay

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Radical Cystectomy ◽

Surrogate Marker ◽

Urothelial Bladder Cancer ◽

Urothelial Bladder ◽

Muscle Invasive

Download Full-text

Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?

European Journal of Cancer ◽

10.1016/j.ejca.2015.11.017 ◽

2016 ◽

Vol 54 ◽

pp. 69-74 ◽

Author(s):

Damien Pouessel ◽

Sylvie Chevret ◽

Frédéric Rolland ◽

Gwenaelle Gravis ◽

Lionel Geoffrois ◽

...

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Locally Advanced ◽

Dose Intensity ◽

Urothelial Bladder Cancer ◽

Urothelial Bladder

Download Full-text